메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

함희진 (강원대학교, 강원대학교 대학원)

지도교수
박선일
발행연도
2016
저작권
강원대학교 논문은 저작권에 의해 보호받습니다.

이용수27

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (3)

초록· 키워드

오류제보하기
초록

서울지역에서 매년 겨울철에 유행하는 급성호흡기질환의 주요원인 바이러스들 중 하나인 인플루엔자 바이러스와 다른 급성호흡기 바이러스들의 검츌율을 알아볼 목적으로 연구를 수행하였다.

서울시내 6개 병의원으로부터 2010년부터 2012년까지 3년간 2,544건의 인후도말 검체들을 채취하여 인플루엔자 바이러스를 검사한 결과, 19.1%(486/2,544)의 인플루엔자 바이러스를 분리하였다. 인플루엔자의 연도별 검출율은 2010년 23.0%(212/923), 2011년 6.4%(47/738) 그리고 2012년 25.7%(227/883)이었고, 유형별로는 A형이 10.8%(275/ 2,544), B형이 8.3%(211/2,544)로 나타났으며, 연령별로는 20-49세의 성인층 환자수가 51.6%로 가장 많았다.

또한, 2,544건의 동일 검체들로부터 32.0%(813/2,544)의 급성호흡기 질병의 원인바이러스를 검출하였는데, human rhinovirus가 40.7%(331/ 813)로 가장 많았고, 그 다음으로 adenovirus 23.9%(194/813), respiratory syncytial virus 14.1%(115/813), para influenza virus 12.3%(100/813), human coronavirus 8.7%(71/813) 순이었다.

바이러스별 임상증상을 분석한 결과, H1N1 pdm09에 의한 인플루엔자 의 경우 발열 100%(14/14), 기침 57.1% (8/14), H3N2인플루엔자 바이러스의 경우 발열 87.2%(75/86), 기침 72.1%(62/86), 인후염 59.3%(51/86), 근육통 55.8%(48/86), 콧물 58.1%(50/86)으로 나타 났다. 파라인플루엔자 바이러스는 발열 61.1%(22/36), 호흡기 세포융합 바이러스는 발열 52.8%(19/36), 기침 55.6%(20/36), 아데노 바이러스 는 발열 87.1%(81/93), 코로나 바이러스는 발열 89.2%(33/37)을 나타냈다.

인플루엔자와 다른 호흡기 바이러스에 의한 급성호흡기 질환은 사망률 자체는 높지 않았지만, 그 발생 규모가 커서 막대한 사회경제적 손실을 초래할 수 있으므로 지속적 감시체계가 필요하였다.

목차

국문초록························································ iii
LIST OF ABBREVIATIONS···································v
LIST OF TABLES············································vii
LIST OF FIGURES······································xi
1 장. 총설············································1
1. 인플루엔자 바이러스·······································1
1) 발생역학··········································1
2) 특성··········································8
3) 병인론·············································13
4) 배양 및 동정방법·····································16
5) 분자생물학적 진단····································17
6) 백신················································19
2. 다른 급성호흡기 바이러스·································23
1) 발생역학 ··········································23
2) 특성··········································30
3) 병인론·············································36
4) 배양 및 동정방법···································44
5) 분자생물학적 진단···································47
6) 백신··········································49
3. 연구목적··········································50
2 장. 급성 호흡기 환자들로부터 분리한 인플루엔자 바이러스의 유행 양상··············································53
1. 서론················································53
2. 재료 및 방법··········································55
3. 결과·············································60
4. 고찰·············································86
3 장. 급성 호흡기 환자들로부터 분리한 다른 호흡기 바이러스의 유행
양상················································92
1. 서론·············································92
2. 재료 및 방법··········································94
3. 결과················································98
4. 고찰················································105
4 장. 급성 호흡기 바이러스 감염빈도, 혼합감염 및 바이러스별 임상 증상 분석·········································113
1. 서론················································113
2. 재료 및 방법··········································115
3. 결과················································118
4. 고찰················································127
5 장. 종합고찰·············································132
6 장. 종합결론·············································137
7 장. 참고문헌·············································140
ABSTRACT·············································157

최근 본 자료

전체보기

댓글(0)

0